Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services
At a glance
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of October 14, 2025; forecast dates can change. Applicant types listed as eligible include state governments, county governments, independent school districts, public colleges & universities, federally recognized tribal governments and 7 more. Cost sharing is not required. It is funded under Assistance Listing 93.233 (National Center on Sleep Disorders Research) and 4 other listings.
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Jul 1, 2025Forecast posted
- Aug 1, 2025 (est.)Full notice expected
- Oct 14, 2025 (est.)Application deadline
- May 1, 2026 (est.)Est. award date
- Posted
- Jul 1, 2025
- Est. close date
- Oct 14, 2025
- Est. award date
- May 1, 2026
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2026
Typical awards for this program (SAM.gov listing for ALN 93.233, not this notice): Grants: $45 to $2,585,120: $457,671. SBIR Phase I - $319,005; Phase II - up to $301,224; STTR Phase I - $128,047; Phase II – up to $654,527
Who can apply
- State governments
- County governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Candidates to the StARRTS program must have completed a R38 program as this is a companion opportunity with limited availability to facilitate transition to independence.
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The NHLBI intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Stimulating Access to Research in Residency Transition Scholar (StARRTS) Career Development program. The goal of the StARRTS program is to help ensure that highly trained scientists are available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NIH Institutes and Centers (ICs) support a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into this area are encouraged to begin to consider applying for this NOFO.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listings
What is an ALN?- 93.233National Center on Sleep Disorders ResearchProgram →
- 93.837Cardiovascular Diseases ResearchProgram →
- 93.838Lung Diseases ResearchProgram →
- 93.839Blood Diseases and Resources ResearchProgram →
- 93.840Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep DisordersProgram →
Reported obligations under ALN 93.233
Historical data · not a predictionAgency contact (as published)
David Schopfer, M.D. National Heart, Lung, and Blood Institute
david.schopfer@nih.gov
301-402-3833
Changes we detected
- Oct 8, 2026: Close date changed
- Oct 8, 2026: Title changed
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around August 1, 2025. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: State governments, County governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Private colleges & universities, For-profit organizations (not small businesses), Small businesses and Others (see notice). Additional restrictions may apply; review the full notice.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-HL-27-010), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Dec 3, 2026
- Who can apply
- Others (see notice)
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 5, 2027 (est.)
- Who can apply
- Small businesses
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jan 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jan 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Feb 16, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- May 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more